Glenmark settles patent suit for with US firm

09 May 2011 Evaluate

Drug firm Glenmark Pharmaceuticals’ subsidiary Glenmark Generics has entered into a settlement and licence agreement with US-based Nycomed to resolve patent infringement lawsuit for fluticasone propionate lotion, used for treating skin pain and itch. Fluticasone propionate 0.05% lotion by Glenmark is generic version of Nycomed's 'Cultivate' lotion.

Under the terms of agreement, Glenmark will be able to market and distribute it's Fluticasone Propionate lotion under a royalty-bearing license from Nycomed US in March 2012.Nycomed had filed a patent infringement suit in the US District Court of New York in December, 2008, challenging Glenmark's ANDA for Fluticasone propionate lotion.The company believes it is entitled to 180 days exclusivity for the product as it is the first generic company to have filed an ANDA for the product.

Glenmark had earlier received final approval from the US health regulator for its generic Fluticasone propionate lotion. The product is used in treating skin pain and itching caused by eczema. According to IMS health sales data for the year ended December, 2010, 'Cultivate' lotion achieved annual sales of nearly $48 million in the American market, Glenmark.

crackcrack

Glenmark Pharma Share Price

1377.55 0.70 (0.05%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...